Creative Medical Technology Holdings Inc
CELZ2.860USD
-0.010-0.35%
Market hours （ET）Quotes delayed by 15 min
7.38MMarket Cap
LossP/E TTM
More Details of Creative Medical Technology Holdings Inc Company
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc Info
Ticker SymbolCELZ
Company nameCreative Medical Technology Holdings Inc
IPO dateMay 01, 2009
CEOMr. Timothy Warbington
Number of employees4
Security typeOrdinary Share
Fiscal year-endMay 01
Address211 E. Osborn Rd.
CityPHOENIX
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code85012
Phone14803992822
Websitehttps://creativemedicaltechnology.com/
Ticker SymbolCELZ
IPO dateMay 01, 2009
CEOMr. Timothy Warbington
Company Executives of Creative Medical Technology Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.81%
The Vanguard Group, Inc.
0.68%
Warbington (Timothy)
0.47%
Citadel Advisors LLC
0.43%
Other
96.72%
Shareholders
Shareholders
Proportion
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.81%
The Vanguard Group, Inc.
0.68%
Warbington (Timothy)
0.47%
Citadel Advisors LLC
0.43%
Other
96.72%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.43%
Corporation
0.88%
Investment Advisor/Hedge Fund
0.88%
Individual Investor
0.49%
Hedge Fund
0.47%
Other
95.85%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
25
71.80K
2.78%
-205.37K
2025Q2
25
242.47K
9.38%
+92.22K
2025Q1
27
239.16K
9.28%
+93.67K
2024Q4
29
67.44K
3.86%
-172.00K
2024Q3
32
114.73K
8.54%
-150.07K
2024Q2
34
115.50K
8.55%
-269.83K
2024Q1
36
151.46K
11.09%
-154.43K
2023Q4
38
64.97K
4.67%
-273.04K
2023Q3
42
127.49K
15.08%
-223.19K
2023Q2
41
127.02K
15.07%
-210.98K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Geode Capital Management, L.L.C.
20.88K
0.81%
+2.61K
+14.28%
Jun 30, 2025
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Jun 30, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Citadel Advisors LLC
11.14K
0.43%
+11.14K
--
Jun 30, 2025
Northern Trust Global Investments
10.00K
0.39%
+10.00K
--
Jun 30, 2025
Allworth Financial, L.P.
4.00K
0.15%
+4.00K
--
Jun 30, 2025
Ameritas Advisory Services, LLC
2.28K
0.09%
+2.28K
--
Jun 30, 2025
Bridgeway Capital Management, LLC
1.85K
0.07%
+1.85K
--
Jun 30, 2025
Northern Trust Investments, Inc.
1.71K
0.07%
+1.71K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Date
Type
Ratio
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
